Introduction and State-of-the-Art Analysis
In conventional oncology, tumor angiogenesis has historically been defined as a process of biological coarctation: the neoplastic mass sends chemical signals aimed at inducing the formation of new blood vessels, thereby securing the nutrient supply necessary for its proliferation. For decades, this paradigm has driven the pharmacological strategy of anti-angiogenesis or starve the tumor approach. However, the clinical outcomes of this strategy have often been characterized as unsatisfactory, or even a flop, when compared to the substantial financial resources and research efforts invested.
The Paradigm Shift: The Orgonomic Perspective
Drawing upon the studies of Wilhelm Reich and the principles of Orgonomic science, the phenomenon of angiogenesis is reinterpreted not as an offensive response of the tumor, but as a defensive response initiated by the organism. In this view, the creation of a localised new vascular system represents the establishment of logistical infrastructure essential for transporting systemic resources to the pathological front.
Dynamics of Orgonomic Potential
The efficacy of this defensive response does not reside in the mere physical presence of the vessels, but rather in the energetic charge of the circulating blood, specifically, of the erythrocytes (red blood cells). The governing principle is the Law of Orgonomic Potential, which dictates that a higher-charged system attracts energy from a lower-charged system.
1) Energy Deficit Scenario
If the patient’s blood, or more precisely the erythrocytes, possesses an energetic charge lower than that of the tumor mass, the latter will act as an attractor, draining vitality from the organism and accelerating the degenerative process.
2) Energy Surplus Scenario
Should the erythrocytes possess a charge higher than that of the neoplastic mass, an inversion of the energetic flow occurs. In this instance, the blood is capable of energetically depleting the tumor, thereby triggering its re-absorption.
Conclusions and Therapeutic Implications
This presentation highlights that the treatment should not be focused on the obstruction of vascular pathways, but rather on the enhancement of the bio-energy of the system. The use of the Orgone Energy Accumulator can be seen as an instrument to increase the blood’s charge above the critical threshold of the tumor. Only through this energetic increase it is possible to transform angiogenesis from a risk into an opportunity to restore health, allowing the organism to re-absorb the tumor mass and restore homeostasis.









